Insights

We’re acknowledged for our strong market insight and technical know-how

Life sciences
Insights

New guidance on the classification of software as medical devices

21 February 2020
Read more
Insights

Shanks v Unilever: an increase in employee compensation claims?

21 February 2020
Read more
Insights

The future of medicinal cannabis: patient need v public policy and regulation

21 February 2020
Read more
Insights

Brexit and the life sciences sector – what are the impacts?

14 February 2020
Read more
News

Penningtons Manches Cooper acts for pioneering medtech business on £4.6 million investment

17 January 2020
Read more
News

Penningtons Manches Cooper advises Oxford Drug Design on equity funding round led by o2h Ventures

3 July 2019
Read more
News

Penningtons Manches advises on sale of Chemtest Group

17 April 2019
Read more
Insights

Contingency legislation covering regulation of medicines, medical devices and clinical trials in a no deal scenario

11 March 2019
Read more
Insights

Implementation is key to transforming the Arc

2 November 2018
Read more
Insights

Brexit no-deal technical notices – implications for the life sciences sector

18 October 2018
Read more
Insights

Penningtons Manches advises on £29 million Series B life sciences funding

20 April 2018
Read more
Insights

Penningtons Manches advises Oxford Vacmedix on £9 million funding round

27 March 2018
Read more
Back to Life sciences